In their study, a bacterium harboring an NDE gene nicX was used to degrade gut nicotine in mice to alleviate smoking-related NASH [8], suggesting that probiotics harboring NDEs may be used in the treatment of smoking-related diseases. The gene discussed is NDE1; the disease is metabolic dysfunction-associated steatohepatitis.